Computer-aided discovery of small molecules targeting the rna splicing activity of hnrnp a1 in castration-resistant prostate cancer - Université de Lille
Article Dans Une Revue Molecules Année : 2019

Computer-aided discovery of small molecules targeting the rna splicing activity of hnrnp a1 in castration-resistant prostate cancer

Résumé

The heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) is a versatile RNA-binding protein playing a critical role in alternative pre-mRNA splicing regulation in cancer. Emerging data have implicated hnRNP A1 as a central player in a splicing regulatory circuit involving its direct transcriptional control by c-Myc oncoprotein and the production of the constitutively active ligand-independent alternative splice variant of androgen receptor, AR-V7, which promotes castration-resistant prostate cancer (CRPC). As there is an urgent need for effective CRPC drugs, targeting hnRNP A1 could, therefore, serve a dual purpose of preventing AR-V7 generation as well as reducing c-Myc transcriptional output. Herein, we report compound VPC-80051 as the first small molecule inhibitor of hnRNP A1 splicing activity discovered to date by using a computer-aided drug discovery approach. The inhibitor was developed to target the RNA-binding domain (RBD) of hnRNP A1. Further experimental evaluation demonstrated that VPC-80051 interacts directly with hnRNP A1 RBD and reduces AR-V7 messenger levels in 22Rv1 CRPC cell line. This study lays the groundwork for future structure-based development of more potent and selective small molecule inhibitors of hnRNP A1(-)RNA interactions aimed at altering the production of cancer-specific alternative splice isoforms.
Fichier principal
Vignette du fichier
molecules-24-00763.pdf (3.06 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03934366 , version 1 (11-01-2023)

Licence

Identifiants

Citer

Lavinia A. Carabet, Eric Leblanc, Nada Lallous, Helene Morin, Fariba Ghaidi, et al.. Computer-aided discovery of small molecules targeting the rna splicing activity of hnrnp a1 in castration-resistant prostate cancer. Molecules, 2019, Molecules (Basel, Switzerland), 24 (4), pp.763. ⟨10.3390/molecules24040763⟩. ⟨hal-03934366⟩

Collections

UNIV-LILLE
13 Consultations
17 Téléchargements

Altmetric

Partager

More